scholarly article | Q13442814 |
P50 | author | Jianzhong Xu | Q51024336 |
Ce Dou | Q58914412 | ||
P2093 | author name string | Hong Jiang | |
Min Hu | |||
Fei Luo | |||
Zhen Cao | |||
Shiwu Dong | |||
Ning Ding | |||
Fei Kang | |||
Tianyong Hou | |||
Zhao Xie | |||
Xiaochao Yang | |||
P2860 | cites work | Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation | Q24311588 |
Inhibition of polyadenylation reduces inflammatory gene induction | Q24608252 | ||
Bone resorption by osteoclasts | Q28145169 | ||
ICSBP/IRF-8: its regulatory roles in the development of myeloid cells | Q28201638 | ||
From estrogen-centric to aging and oxidative stress: a revised perspective of the pathogenesis of osteoporosis | Q28385120 | ||
Acteoside suppresses RANKL-mediated osteoclastogenesis by inhibiting c-Fos induction and NF-κB pathway and attenuating ROS production | Q28535889 | ||
A new superoxide-generating oxidase in murine osteoclasts | Q28587361 | ||
Osteoclast differentiation and activation | Q29547556 | ||
Cordyceps: a traditional Chinese medicine and another fungal therapeutic biofactory? | Q30368268 | ||
FoxO proteins restrain osteoclastogenesis and bone resorption by attenuating H2O2 accumulation | Q33587373 | ||
Oxygen-derived free radicals stimulate osteoclastic bone resorption in rodent bone in vitro and in vivo | Q34244296 | ||
Update on denosumab in postmenopausal osteoporosis--recent clinical data | Q34300462 | ||
Anti-inflammatory effects of cordycepin in lipopolysaccharide-stimulated RAW 264.7 macrophages through Toll-like receptor 4-mediated suppression of mitogen-activated protein kinases and NF-κB signaling pathways | Q34386876 | ||
MiR-7b directly targets DC-STAMP causing suppression of NFATc1 and c-Fos signaling during osteoclast fusion and differentiation. | Q53473415 | ||
Cordycepin suppresses TNF-α-induced NF-κB activation by reducing p65 transcriptional activity, inhibiting IκBα phosphorylation, and blocking IKKγ ubiquitination | Q85295108 | ||
Late stages of the synchronized macrophage fusion in osteoclast formation depend on dynamin | Q85841218 | ||
Dual Effect of Cyanidin on RANKL-Induced Differentiation and Fusion of Osteoclasts | Q86419329 | ||
Cordycepin (3'-deoxyadenosine) down-regulates the proinflammatory cytokines in inflammation-induced osteoporosis model | Q87226184 | ||
Cordycepin (3'-deoxyadenosine) attenuates age-related oxidative stress and ameliorates antioxidant capacity in rats | Q87353386 | ||
Calcium metabolism and oxidative stress in bone fractures: role of antioxidants. | Q34640274 | ||
Epidemiology and outcomes of osteoporotic fractures | Q34671295 | ||
Calcium signaling in osteoclasts | Q34810150 | ||
A crucial role for thiol antioxidants in estrogen-deficiency bone loss | Q35919837 | ||
Pharmacological actions of Cordyceps, a prized folk medicine | Q36341944 | ||
Advances in bone biology: the osteoclast | Q36825193 | ||
The Keap1/Nrf2 protein axis plays a role in osteoclast differentiation by regulating intracellular reactive oxygen species signaling | Q37095379 | ||
NADPH oxidase 4 limits bone mass by promoting osteoclastogenesis | Q37259220 | ||
Oxidative stress, free radicals and bone remodeling | Q37291314 | ||
Interferon regulatory factor-8 regulates bone metabolism by suppressing osteoclastogenesis | Q37370702 | ||
Cordyceps fungi: natural products, pharmacological functions and developmental products | Q37395042 | ||
JNK/FOXO-mediated neuronal expression of fly homologue of peroxiredoxin II reduces oxidative stress and extends life span | Q37447693 | ||
Sense and sensitivity: FOXO and ROS in cancer development and treatment | Q37774661 | ||
p38 and JNK MAPK pathways control the balance of apoptosis and autophagy in response to chemotherapeutic agents | Q38170919 | ||
The inhibition of RANK-ligand in the management of postmenopausal osteoporosis and related fractures: the role of denosumab | Q38193181 | ||
Antioxidants, like coenzyme Q10, selenite, and curcumin, inhibited osteoclast differentiation by suppressing reactive oxygen species generation | Q38466415 | ||
Cordycepin Suppresses Expression of Diabetes Regulating Genes by Inhibition of Lipopolysaccharide-induced Inflammation in Macrophages | Q38488996 | ||
Nuclear Nrf2 induction by protein transduction attenuates osteoclastogenesis | Q38956349 | ||
Cordycepin induces S phase arrest and apoptosis in human gallbladder cancer cells. | Q38968922 | ||
Fluid flow-induced calcium response in osteoclasts: signaling pathways | Q39006749 | ||
Apoptosis induction of human prostate carcinoma cells by cordycepin through reactive oxygen species‑mediated mitochondrial death pathway | Q39215740 | ||
Cordycepin inhibits albumin-induced epithelial-mesenchymal transition of renal tubular epithelial cells by reducing reactive oxygen species production | Q39431747 | ||
Induction of apoptosis by cordycepin via reactive oxygen species generation in human leukemia cells | Q39594556 | ||
High oxygen tension prolongs the survival of osteoclast precursors via macrophage colony-stimulating factor | Q39923235 | ||
Antitumor effect of cordycepin (3'-deoxyadenosine) on mouse melanoma and lung carcinoma cells involves adenosine A3 receptor stimulation. | Q40317083 | ||
FOXO transcription factor activation by oxidative stress mediated by the small GTPase Ral and JNK. | Q40493379 | ||
An essential role for free radicals and derived species in signal transduction. | Q41353458 | ||
Nrf2 regulates ROS production by mitochondria and NADPH oxidase | Q41883957 | ||
Interferon regulatory factor 8 protects against cerebral ischaemic-reperfusion injury. | Q42237002 | ||
Macrophage-colony-stimulating factor-induced activation of extracellular-regulated kinase involves phosphatidylinositol 3-kinase and reactive oxygen species in human monocytes | Q44223897 | ||
Reactive oxygen species mediate RANK signaling in osteoclasts. | Q45142284 | ||
A crucial role for reactive oxygen species in RANKL-induced osteoclast differentiation | Q46427712 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 4 | |
P304 | page(s) | 231 | |
P577 | publication date | 2016-04-20 | |
P1433 | published in | Nutrients | Q7070485 |
P1476 | title | Cordycepin Prevents Bone Loss through Inhibiting Osteoclastogenesis by Scavenging ROS Generation | |
P478 | volume | 8 |
Q91045130 | A novel nucleoside rescue metabolic pathway may be responsible for therapeutic effect of orally administered cordycepin |
Q58553046 | Cordycepin Accelerates Osteoblast Mineralization and Attenuates Osteoclast Differentiation In Vitro |
Q92642434 | Cordycepin prevents radiation ulcer by inhibiting cell senescence via NRF2 and AMPK in rodents |
Q47137712 | Cordycepin stimulates autophagy in macrophages and prevents atherosclerotic plaque formation in ApoE-/- mice. |
Q52331539 | Graphene-Based MicroRNA Transfection Blocks Preosteoclast Fusion to Increase Bone Formation and Vascularization. |
Q47100432 | Modulation Effects of Cordycepin on Voltage-Gated Sodium Channels in Rat Hippocampal CA1 Pyramidal Neurons in the Presence/Absence of Oxygen |
Q33851991 | Osthole Enhances Osteogenesis in Osteoblasts by Elevating Transcription Factor Osterix via cAMP/CREB Signaling In Vitro and In Vivo. |
Q91942005 | Pregnenolone Inhibits Osteoclast Differentiation and Protects Against Lipopolysaccharide-Induced Inflammatory Bone Destruction and Ovariectomy-Induced Bone Loss |
Q64082993 | The polyadenylation inhibitor cordycepin reduces pain, inflammation and joint pathology in rodent models of osteoarthritis |
Q92815759 | Therapeutic Potential and Biological Applications of Cordycepin and Metabolic Mechanisms in Cordycepin-Producing Fungi |
Search more.